Intro to Hypothalamus and Feeding Behavior Study Guide to Feeding Behavior

Overview of the Hypothalamus as the Health Management System

The hypothalamus serves as the body’s primary health management system, exerting control over multiple physiological domains.
Control of the Autonomic Nervous System (ANS): The hypothalamus manages visceral responses to maintain homeostasis, which involves keeping the internal environment stable despite external changes. * Homeostasis Functions: * Regulation of body temperature through mechanisms such as shivering and sweating. * Maintenance of blood volume. * Regulation of blood glucose levels. * Sympathetic Nervous System Control ("Fight or Flight"): * Increases heart rate. * Depresses digestive processes. * Mobilizes glucose for immediate energy use. * Parasympathetic Nervous System Control: * Decreases heart rate. * Activates digestive processes.
Control of the Endocrine System: The hypothalamus manages the release of hormones through the pituitary gland to regulate various body functions: * Mobilization of energy stores. * Regulation of ovulation and spermatogenesis. * Stimulation of growth. * Stimulation of milk secretion.
Contribution to Behavior (Motor System): The hypothalamus influences motor outputs related to survival and basic drives: * Feeding behavior. * Sleep-wake cycles. * Circadian rhythms. * Sexual behavior. * Emotions and fear responses.

Modes of Communication Within the Hypothalamus

Autonomic Nervous System (ANS): Characterized by extensive interconnections throughout the body. It controls many organs, blood vessels, and glands simultaneously to coordinate widespread visceral responses.
Neuroendocrine System: Involves the release of hormones directly into the bloodstream. This mode is described as slow and widespread in its effects.
Motor System: Utilizes point-to-point communication. It is specific, brief, and fast in its execution of behavioral responses.

Hypothalamic Control of the Posterior Pituitary: ADH Pathway

Trigger for Response: The process begins with low water intake, which results in low blood pressure.
Detection Mechanisms: * Pressure receptors located within the cardiovascular system detect the drop in blood pressure. * Salt receptors located within the hypothalamus detect changes in osmolarity.
Hormonal Release: The hypothalamus triggers the release of Vasopressin, also known as Antidiuretic Hormone ( $ADH$ ).
Renal Action: $ADH$ leads to water retention by the kidneys.
Secondary Cascade: * The kidneys release the enzyme Renin. * Renin facilitates the production of Angiotensin II.
Sensing and Behavioral Feedback: * Angiotensin II is sensed at the Subfornical organ. * Detection of Angiotensin II leads to more release of $ADH$ and the activation of the lateral hypothalamus to drive thirst/drinking behavior.

The Stress Response: CRH and ACTH Control of Cortisol

Initial Secretion: When cortisol levels are low, the hypothalamus secretes Corticotropin-Releasing Hormone ( $CRH$ ).
Pituitary Activation: $CRH$ stimulates the anterior pituitary gland to release Adrenocorticotropic Hormone ( $ACTH$ ).
Adrenal Action: $ACTH$ acts on the adrenal cortex, triggering the release of cortisol into the bloodstream.
Functions of Cortisol: * Increases blood glucose levels to provide energy during stress. * Reduces inflammation. * Regulates energy expenditure and usage.
Negative Feedback Loop: As cortisol levels rise, they send signals back to the brain to suppress the secretion of both $CRH$ and $ACTH$ , thereby maintaining physiological balance.

Role of Insulin and Sugar Regulation

Post-Prandial Process: 1. Following a meal, carbohydrates are broken down into glucose, which enters the bloodstream. 2. Elevated blood glucose levels trigger the pancreas to release insulin. 3. Insulin binds to specific receptors on liver, muscle, and fat cells, facilitating the entry of glucose into these cells. 4. Cells utilize the glucose for immediate energy or store it as glycogen. 5. Once glycogen stores are reached, excess glucose is converted into triglycerides and stored as body fat (occurring when total calorie intake exceeds energy expenditure). 6. Dietary fat (primarily triglycerides) is broken down into fatty acids via digestion and cellular metabolism.
Blood Sugar Maintenance: Insulin effectively lowers blood sugar to keep it within a healthy range. If insulin is insufficient or ineffective (as seen in diabetes), blood glucose remains chronically elevated.
Insulin and the Brain: The brain does not require insulin to facilitate glucose uptake into neurons. However, insulin does bind to receptors in the hypothalamus, where it serves as a signal of energy abundance.

Leptin and Obesity Research

Leptin Definition: A hormone released into the bloodstream by fat cells to signal the body's fat reserves.
The Obese Mouse Model: Research into genetic obesity in mice involved several key findings: * Normal Mouse: Maintains standard weight and energy balance. * Obese ( $ob/ob$ ) Mouse: Lacks the ability to produce leptin, resulting in overeating and obesity.
Parabiosis Studies: Experiments involving a shared blood supply between mice: * Linking a normal mouse with an obese mouse (parabiosis) results in the obese mouse losing weight as it receives leptin from the normal partner's blood.
Leptin Treatment: Administering leptin to an obese mouse results in a reduction of weight.
Human Application: Clinical cases have identified leptin deficiency in humans as a cause for severe obesity.

Hypothalamic Circuitry in Feeding Control

The Arcuate Nucleus: Acts as a primary sensor for leptin levels in the blood. It controls the activity of the paraventricular nucleus and the lateral hypothalamic area.
The Paraventricular Nucleus: Regulates the Autonomic Nervous System (ANS) and the endocrine system.
The Lateral Hypothalamic Area: Controls the motor system responses necessary for feeding behavior.

Case 1: High Leptin Levels (Abundant Fat Stores)

Recognition: Leptin binds to receptors in neurons of the arcuate nucleus.
Peptide Release: Arcuate nucleus neurons release the peptides $\alpha\text{MSH}$ (Alpha-Melanocyte-Stimulating Hormone) and $CART$ (Cocaine- and Amphetamine-Regulated Transcript).
Anorectic Pathways (Stop Eating): * $\alpha\text{MSH}$ and $CART$ inhibit the neurons in the lateral hypothalamus that would otherwise activate feeding behavior. * $\alpha\text{MSH}$ and $CART$ activate the paraventricular nucleus.
Physiological Outcome: * Activation of the Sympathetic Nervous System increases energy expenditure. * The thyroid gland is activated to increase metabolic rate. * Appetite is reduced.

Case 2: Low Leptin Levels (Fat Stores Needed)

Recognition: Low leptin levels are sensed by different neurons in the arcuate nucleus.
Peptide Release: These neurons release $NPY$ (Neuropeptide Y) and $AgRP$ (Agouti-Related Peptide).
Orexigenic Pathways (Promote Eating): * $NPY$ and $AgRP$ activate neurons in the lateral hypothalamus. * The lateral hypothalamus releases secondary neuropeptides: $MCH$ (Melanin-Concentrating Hormone) and Orexin, both of which promote appetite and stimulate motor systems (cortex, brainstem) for feeding. * $NPY$ and $AgRP$ inhibit the paraventricular nucleus, reducing sympathetic activity.
Physiological Outcome: Promotion of eating behavior and conservation of energy.

Short-term Control of Feeding

Cephalic Phase: Early parasympathetic responses such as salivation and the mobilization of digestive enzymes.
Hunger Signals: An empty stomach releases Ghrelin, which specifically activates the $NPY$ and $AgRP$ -containing cells in the arcuate nucleus to stimulate hunger.
Satiety Signals: * Stomach Distension: A full stomach activates the nucleus of the solitary tract via the vagus nerve, which inhibits feeding behavior. * $CCK$ (Cholecystokinin): Released from the intestines after eating, signalling satiety via the vagus nerve. * Insulin: Released by the pancreas (sensing abundance via the hypothalamus) to signal satiety. Note: In this context, insulin acts as an energy signal, not just for glucose uptake.

Modern Medical Interventions: Ozempic

Mechanism of Action: Ozempic (semaglutide) mimics the natural hormone $GLP-1$ (Glucagon-Like Peptide-1), which is typically released after eating.
Physiological Effects: * Increases insulin release from the pancreas when blood sugar is high. * Reduces glucagon (the hormone that signals the liver to release sugar). * Slows gastric emptying (how quickly food leaves the stomach) so sugar enters the blood more gradually. * Targets the brain to reduce hunger sensations, facilitating weight loss.

Eating Disorders and Neurological Factors

Anorexia: * Involves alterations in Ghrelin and the $NPY/AgRP$ pathways. * There is a significant genetic component. * Associated with alterations in the Dopamine ( $DA$ ) system.
Bulimia: * Linked to genetic vulnerability. * Characterized by altered Serotonin and Dopamine signaling, which affects mood, impulse control, and appetite.
Common Influences: Both disorders are influenced by cultural bias and various psychological factors.

Other Systems in Hunger and Behavior

Endocannabinoid System: Cannabis is known to stimulate hunger. Endogenous cannabinoids, such as Anandamide, stimulate hunger when injected directly into the hypothalamus.
Gut Microbiota (Microbiome): * The human body contains approximately $2.5-5\text{ pounds}$ of gut microbes (bacteria, viruses, fungi). * These microbes make up more than half of the contents of the large intestine. * Microbiome alterations influence mood, cognition, and social behavior. * Disruptions are associated with autism, schizophrenia, bipolar disorder, multiple sclerosis, Parkinson’s disease, and obesity. * Treatment: Fecal transplants are mentioned as a potential therapeutic intervention to address microbiome imbalances.